Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00815425 · ClinicalTrials.gov registry record

Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (The CLEAR Registry)

A clinical trial, sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).

Completed
Registry status
1,613
Enrollment target

NCT00815425 is a clinical trial that has completed, run by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). The registered enrollment target is 1,613 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00815425 has completed, sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).

COMPLETED
Registry status
1,613 participants
Enrollment target

Study Summary

Rheumatoid arthritis (RA) is a long-term autoimmune disease that is characterized by pain, stiffness, inflammation, swelling, and sometimes destruction of joints. RA usually requires lifelong treatment, including medications, physical therapy, exercise, education, and possibly surgery, but the course and severity of the disease can differ significantly from person to person. The purpose of this study is to identify genetic and other factors that determine the severity of RA in African Americans.

Trial Details

FieldValue
Enrollment Target 1,613 participants
Start Date 2000-09
Est. Completion 2012-03

What the Registry Record Tells You About NCT00815425

The ClinicalTrials.gov registry entry for NCT00815425 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,613 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), which has 93 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00815425 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00815425 about?

NCT00815425 is a clinical study titled "Consortium for the Longitudinal Evaluation of African Americans With Early Rheumatoid Arthritis (The CLEAR Registry)". Rheumatoid arthritis (RA) is a long-term autoimmune disease that is characterized by pain, stiffness, inflammation, swelling, and sometimes destruction of joints. RA usually requires lifelong treatment, including medications, physical therapy, exercise, education, and possibly surgery, but the cours...

What is the current status of trial NCT00815425?

This trial is currently completed. The enrollment target is 1,613 participants. The study started on 2000-09. Estimated completion is 2012-03.

Who is sponsoring clinical trial NCT00815425?

This trial is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), which has 93 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.